Biotech SF
San Francisco Bay Area biotech stories.
Thursday, April 7, 2011
Sangamo to sell 6.7 million shares
Sangamo BioSciences Inc. will sell 6.7 million shares of stock in a public offering underwritten by Barclays Capital Inc.
Richmond-based Sangamo (NASDAQ: SGMO) will give Barclays a 30 day option to buy up to 1.005 million more shares.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment